ATE557101T1 - Verfahren und zusammensetzungen zur bestimmung eines transplantationstoleranten phänotyps in einem individuum - Google Patents

Verfahren und zusammensetzungen zur bestimmung eines transplantationstoleranten phänotyps in einem individuum

Info

Publication number
ATE557101T1
ATE557101T1 AT05723099T AT05723099T ATE557101T1 AT E557101 T1 ATE557101 T1 AT E557101T1 AT 05723099 T AT05723099 T AT 05723099T AT 05723099 T AT05723099 T AT 05723099T AT E557101 T1 ATE557101 T1 AT E557101T1
Authority
AT
Austria
Prior art keywords
methods
compositions
subject
tolerant phenotype
transplantation
Prior art date
Application number
AT05723099T
Other languages
English (en)
Inventor
Elaine Mansfield
Minnie Sarwal
Sophie Brouard
Jean-Paul Soulilou
Original Assignee
Univ Leland Stanford Junior
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior, Inst Nat Sante Rech Med filed Critical Univ Leland Stanford Junior
Application granted granted Critical
Publication of ATE557101T1 publication Critical patent/ATE557101T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
AT05723099T 2004-01-21 2005-01-20 Verfahren und zusammensetzungen zur bestimmung eines transplantationstoleranten phänotyps in einem individuum ATE557101T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53843904P 2004-01-21 2004-01-21
US57147104P 2004-05-14 2004-05-14
PCT/US2005/004799 WO2005070086A2 (en) 2004-01-21 2005-01-20 Methods and compositions for determining a graft tolerant phenotype in a subject

Publications (1)

Publication Number Publication Date
ATE557101T1 true ATE557101T1 (de) 2012-05-15

Family

ID=34811352

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05723099T ATE557101T1 (de) 2004-01-21 2005-01-20 Verfahren und zusammensetzungen zur bestimmung eines transplantationstoleranten phänotyps in einem individuum

Country Status (5)

Country Link
US (2) US8932808B1 (de)
EP (1) EP1718768B1 (de)
AT (1) ATE557101T1 (de)
CA (2) CA2553551C (de)
WO (1) WO2005070086A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE46843E1 (en) 2005-03-14 2018-05-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for evaluating graft survival in a solid organ transplant recipient
EP2604703B1 (de) * 2005-03-14 2017-02-01 The Board of Trustees of the Leland Stanford Junior University Verfahren zur Bewertung der Haltbarkeit eines Pfropfs im Körper eines Empfängers fester Organtransplantate
CA2653071A1 (en) 2006-05-25 2007-12-06 Sophie Brouard Methods for diagnosing and treating graft rejection and inflammatory conditions
EP2066809A2 (de) * 2006-08-28 2009-06-10 Source Precision Medicine Genexpressionsprofilierung zur identifikation, überwachung und behandlung einer transplantatabstossung
US20080131441A1 (en) * 2006-09-26 2008-06-05 Manikkam Suthanthiran Methods of Using FOXP3 Levels to Predict the Outcome of Organs Undergoing Acute Rejection
EP1990425A1 (de) * 2007-05-10 2008-11-12 Tcland R Diagnose von Immuntransplantatstoleranz
EP2088205A1 (de) 2008-02-11 2009-08-12 Institut National De La Sante Et De La Recherche Medicale (Inserm) PSMB10: Diagnosemarker und therapeutisches Target für chronische Abstoßung
WO2010021696A1 (en) 2008-08-18 2010-02-25 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for determining a graft tolerant phenotype in a subject
WO2010070043A1 (en) * 2008-12-19 2010-06-24 INSERM (Institut National de la Santé et de la Recherche Médicale) Biomarkers for the diagnosis of renal allograft and kidney status
ES2492498T3 (es) 2009-01-15 2014-09-09 The Board Of Trustees Of The Leland Stanford Junior University Panel de biomarcadores para el diagnóstico y la predicción de rechazo de injerto
EP2507630B1 (de) 2009-12-02 2017-01-25 The Board of Trustees of The Leland Stanford Junior University Biomarker zur bestimmung eines allotransplantattoleranten phänotyps
WO2011119980A1 (en) 2010-03-25 2011-09-29 The Board Of Trustees Of The Leland Stanford Junior University Protein and gene biomarkers for rejection of organ transplants
US8962261B2 (en) 2011-04-06 2015-02-24 The Board Of Trustees Of The Leland Stanford Junior University Autoantibody biomarkers for IGA nephropathy
WO2014036444A1 (en) * 2012-08-30 2014-03-06 Abbott Laboratories Prame detection assays
WO2016048388A1 (en) 2014-09-26 2016-03-31 Somalogic, Inc. Cardiovascular risk event prediction and uses thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994076A (en) 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
US20030104371A1 (en) 1997-09-24 2003-06-05 Strom Terry B. Methods of evaluating transplant rejection
US6607879B1 (en) 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression
ATE396399T1 (de) 1998-03-31 2008-06-15 Asahi Kasei Pharma Corp Verfahren zur untersuchung der iga-nephropathie
US20030113744A1 (en) 2001-05-11 2003-06-19 O' Toole Margot M. Methods for diagnosing and treating ischemia and reperfusion injury and compositions thereof
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
AU2003291134A1 (en) 2002-11-21 2004-06-18 Genzyme Corporation Use of diamide derivatives for inhibiting chronic tissue transplant rejection
CA2516013C (en) 2003-02-14 2014-05-13 Beth Israel Deaconess Medical Center, Inc. Predicting graft rejection
US7892745B2 (en) 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
JP4717810B2 (ja) 2003-06-20 2011-07-06 ユニバーシティ オブ フロリダ リサーチ ファウンデーション インコーポレイテッド １型糖尿病と２型糖尿病を識別するためのバイオマーカー
WO2005054503A2 (en) 2003-12-03 2005-06-16 Novartis Ag Biomarkers for graft rejection
BRPI0509754A (pt) 2004-04-08 2007-10-16 Novartis Ag inibidores de proteìna quinase c para o tratamento de doenças auto-imunes e de rejeição a transplante
US7820382B2 (en) 2004-08-03 2010-10-26 Bauer A Robert Method for the early detection of breast cancer, lung cancer, pancreatic cancer and colon polyps, growths and cancers as well as other gastrointestinal disease conditions and the preoperative and postoperative monitoring of transplanted organs from the donor and in the recipient and their associated conditions related and unrelated to the organ transplantation
EP2604703B1 (de) * 2005-03-14 2017-02-01 The Board of Trustees of the Leland Stanford Junior University Verfahren zur Bewertung der Haltbarkeit eines Pfropfs im Körper eines Empfängers fester Organtransplantate
US7666596B2 (en) 2005-05-23 2010-02-23 University Of Alberta Tissue rejection
EP1731620A1 (de) 2005-06-07 2006-12-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methode zur Diagnose von Immun-Transplantatstoleranz
ES2624863T3 (es) 2005-06-08 2017-07-17 Millennium Pharmaceuticals, Inc. Métodos para identificación, evaluación, y tratamiento de pacientes con terapia de cáncer
WO2007050588A2 (en) 2005-10-25 2007-05-03 Renovar Incorporated Systems and methods for characterizing conditions of organs for transplantation
CN101416063A (zh) 2006-02-06 2009-04-22 拉帕波特家族医学科学研究所 用于诊断t1dm的方法和试剂盒
GB0605217D0 (en) 2006-03-15 2006-04-26 Novartis Ag Method and compositions for assessing acute rejection
GB0607943D0 (en) 2006-04-21 2006-05-31 Novartis Ag Biomarkers for chronic transplant dysfunction
CA2650507A1 (en) 2006-04-27 2007-11-08 Universite De Montreal Assessment and reduction of risk of graft-versus-host disease
WO2008084331A2 (en) 2006-06-21 2008-07-17 Hopitaux Universitaires De Geneve Biomarkers for renal disorders
EP2049713A4 (de) 2006-07-21 2010-06-16 Univ Alberta Gewebeabstossung
EP2066809A2 (de) 2006-08-28 2009-06-10 Source Precision Medicine Genexpressionsprofilierung zur identifikation, überwachung und behandlung einer transplantatabstossung
US20110189680A1 (en) 2008-05-30 2011-08-04 The University Of British Columbia Methods of Diagnosing Rejection of a Kidney Allograft Using Genomic or Proteomic Expression Profiling
CN102124340B (zh) 2008-06-02 2014-12-17 卫材R&D管理有限公司 IgA肾病的检查方法和检查试剂盒
WO2010021696A1 (en) 2008-08-18 2010-02-25 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for determining a graft tolerant phenotype in a subject
KR100928403B1 (ko) 2008-10-01 2009-11-26 경북대학교 산학협력단 티지비엠 신증의 진단용 조성물 및 키트
JP2013528799A (ja) 2010-05-13 2013-07-11 ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー 神経変性疾患の検知および診断のための診断用自己抗体プロファイル

Also Published As

Publication number Publication date
CA2553551A1 (en) 2005-08-04
WO2005070086A3 (en) 2006-09-14
CA2553551C (en) 2020-12-15
CA2957704A1 (en) 2005-08-04
EP1718768B1 (de) 2012-05-09
WO2005070086A2 (en) 2005-08-04
US20140206566A1 (en) 2014-07-24
US8932808B1 (en) 2015-01-13
EP1718768A4 (de) 2007-10-17
EP1718768A2 (de) 2006-11-08

Similar Documents

Publication Publication Date Title
ATE557101T1 (de) Verfahren und zusammensetzungen zur bestimmung eines transplantationstoleranten phänotyps in einem individuum
Cahanovitc et al. Ectomycorrhizal fungi mediate belowground carbon transfer between pines and oaks
Corbin et al. Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
Bermingham et al. Vicariance biogeography in the Pleistocene and speciation in North American wood warblers: a test of Mengel's model.
Bahram et al. A single European aspen (Populus tremula) tree individual may potentially harbour dozens of Cenococcum geophilum ITS genotypes and hundreds of species of ectomycorrhizal fungi
DE602005013957D1 (de) Verfahren zur durchführung von vollbluttests
WO2006099421A3 (en) Methods and compositions for evaluating graft survival in a solid organ transplant recipient
WO2007103374A3 (en) Toxicity screening methods
EP2212700B8 (de) Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
ATE469656T1 (de) Verfahren und reagentien zur diagnose von hantavirusinfektionen
WO2008033427A3 (en) Compositions and methods for detection of lysosomal storage disease
Jo et al. Impact of mouse contamination in genomic profiling of patient-derived models and best practice for robust analysis
Zhong et al. Correlation between imatinib trough concentration and efficacy in Chinese chronic myelocytic leukemia patients
WO2011133770A3 (en) Salivary protein markers for detection of breast cancer
Perez‐Lamarque et al. Analysing diversification dynamics using barcoding data: The case of an obligate mycorrhizal symbiont
MX2021009264A (es) Metodo de caracterizacion de particulas visibles y/o subvisibles en agentes biologicos.
MX2009006744A (es) Panel de padecimiento cardiovascular autoinmune y metodos de utilizacion del mismo.
Ilhan et al. Leukemic stem cells shall be searched in the bone marrow before “tyrosine kinase inhibitor‐discontinuation” in chronic myeloid leukemia
ATE544073T1 (de) Verfahren zur messung immunsuppressiver tacrolimus-, sirolimus- und cyclosporin-a- komplexe in einer blutprobe
Fisher et al. Sonicate fluid cellularity predicted by transcriptomic deconvolution differentiates infectious from non-infectious arthroplasty failure
FI20040255A7 (fi) Menetelmä pre-eklampsian riskin havaitsemiseksi
ATE503846T1 (de) Verfahren zur diagnose eines ovarialkarzinoms
NZ551782A (en) Agents and methods for diagnosing stress
WO2008147206A3 (en) Means and methods for classifying samples of multiple sclerosis patients
ATE475098T1 (de) Verfahren zur messung von plasmaspiegeln von pentraxin ptx3